Menu
| Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
|---|---|---|---|---|---|---|---|---|
| BIIB | BIOGEN INC | 4.06% | 827,600 | $214,158,052 | 270,800 | 48.64% | $258.77 | 13F |
| LLY | ELI LILLY & CO | 4.04% | 365,400 | $212,998,968 | 179,400 | 96.45% | $582.92 | 13F |
| EWTX | Edgewise Therapeutics, Inc. | 3.08% | 14,756,096 | $162,317,056 | 188,920 | 1.30% | Form 4 | |
| SRRK | SCHOLAR ROCK HLDG CORP | 1.51% | 4,245,000 | $79,806,000 | 2,211,211 | 108.72% | $18.8 | 13F |
| PCVX | VAXCYTE INC | 1.37% | 1,153,091 | $72,414,115 | 145,943 | 14.49% | $62.8 | 13F |
| VRTX | VERTEX PHARMACEUTICALS INC | 1.35% | 175,200 | $71,287,128 | 9,800 | 5.93% | $406.89 | 13F |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1.30% | 519,279 | $68,420,201 | 103,379 | 24.86% | $131.76 | 13F |
| SRPT | SAREPTA THERAPEUTICS INC | 1.28% | 697,500 | $67,259,925 | 168,300 | 31.8% | $96.43 | 13F |
| NTRA | NATERA INC | 1.13% | 954,481 | $59,788,690 | 33,900 | 3.68% | $62.64 | 13F |
| RCM | R1 RCM INC | 0.96% | 4,803,200 | $50,769,824 | 1,362,200 | 39.59% | $10.57 | 13F |
| ALXO | ALX ONCOLOGY HLDGS INC | 0.87% | 3,095,000 | $46,084,550 | 224,000 | 7.8% | $14.89 | 13F |
| SNDX | SYNDAX PHARMACEUTICALS INC | 0.72% | 1,749,000 | $37,795,890 | 465,000 | 36.21% | $21.61 | 13F |
| ARGX | ARGENX SE | 0.61% | 84,600 | $32,184,378 | 52,000 | 159.51% | $380.43 | 13F |
| ACET | Adicet Bio, Inc. | 0.39% | 9,772,598 | $19,838,374 | 1,450,458 | 17.43% | 13D | |
| IMTX | IMMATICS N.V | 0.31% | 1,543,407 | $16,252,076 | 493,207 | 46.96% | $10.53 | 13F |
| HRTX | HERON THERAPEUTICS INC | 0.19% | 5,928,591 | $10,078,605 | 5,125,891 | 638.58% | $1.7 | 13F |
| MORF | MORPHIC HLDG INC | 0.15% | 273,400 | $7,895,792 | 64,900 | 31.13% | $28.88 | 13F |
| IKNA | IKENA ONCOLOGY INC | 0.13% | 3,539,358 | $6,972,535 | 353,192 | 11.09% | $1.97 | 13F |
| NSPR | INSPIREMD INC | 0.11% | 2,133,405 | $5,994,868 | 273,000 | 14.67% | $2.81 | 13F |